Factors influencing the rate of fibrosis progression in chronic hepatitis C

Digestive Diseases and Sciences

Volumn 49, Issue 11-12, 2004, Pages 1971-1976

  Fernández Rodriguez, Conrado M ^a   Gutiérrez, Maria Luisa ^a   Serrano, Pilar López ^a   Lledó, José L ^a   Santander, Cecilio ^a   Fernández, Teresa Pérez ^a   Tomás, Esperanza ^a   Cacho, Guillermo ^a   Nevado, Manuel ^a   Casas, Maria Luisa ^a  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

Author keywords

Alcohol intake; Chronic hepatitis C; Fibrosis progression; Hepatic steatosis; Iron overload

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; IRON;

ADULT; ALCOHOL CONSUMPTION; ALKALINE PHOSPHATASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FATTY LIVER; FEMALE; FERRITIN BLOOD LEVEL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS C; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON OVERLOAD; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADULT; DISEASE PROGRESSION; ETHANOL; FATTY LIVER; FEMALE; FERRITINS; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 13644252243     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-004-9603-2     Document Type: Article

References (34)

1. Seeff LB: The natural history of hepatitis C. A quandary. Hepatology 28:1710-1711, 1998
2. Bataller R, North KE, Brenner DA: Genetic polymorphisms and the progression of liver fibrosis: A critical appraisal. Hepatology 37:493-503, 2003
3. Wright M, Goldin R, Hellier S, et al.: Factor Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection. Gut 8:1206-1210, 2003
4. Renou C, Halfon P, Pol S, Cacoub P, Jouve E, Bronowicki JP, Arpurt JP, Rifflet H, Picon M, Causse X, Canva V, Denis J, Tran A, Bourliere M, Ouzan D, Pariente A, Dantin S, Alric L, Cartier V, Reville M, Caillat-Zucman S: Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferases levels. Gut 51:585-590, 2002
5. Boyer N, Marcelin P: Pathogenesis, diagnosis and management of hepatitis C. J. Hepatol (Suppl 1):113-128, 2000
6. Ghany MG, Kleiner DE, Alter H, et al.: Progression of fibrosis in chronic hepatitis C. Gastroenterology 124:97-104, 2003
7. Poynard T, Bedossa P, Opolon: Natural history of liver fibrosis progression in patients with chronic hepatitis C. The Obsvir, METAVIR, CLINIVIR and DOSCVIR groups. Lancet 22(349):825-832, 1997
8. Lagging LM, Westin J, Svensson E, Aires N, Dhilon AP, Lindhl M, Norkrans G: Progression of fibrosis in untreated patients with hepatitis C infection. Liver 22:136-144, 2002
9. Jain SK, Pemberton PW, Smith A, McMahon RF, Buerrows PC, Abotwerat A, Warnes TW: Oxidative stress in chronic hepatitis C: Not just a feature of late stage disease. J Hepatol 36:805-811, 2002
10. Pietrangelo A: Iron, oxidative stress and liver fibrogenesis. J Hepatol 28 (Suppl 1):8-13, 1998
11. Peters MG, Terrault NA: Alcohol use and hepatitis C. Hepatology 36(5, Suppl 1):S220-S225, 2002
12. Thorbun D, Curry G, Spooner R, Spence E, Oien K, Halls D, Fox R, McCruden EAB, McSween RMN, Mills PR: The role of iron and hemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C. Gut 50:248-252, 2002
13. Serfaty L, Poujol-Robert A, Carbonell N, Chaouzillieres O, Poupon RR, Poupon R: Effect of the interaction between steatosis and alcohol intake on liver fibrosis progression in chronic hC. Am J Gastroenterol 977:1807-1812, 2002
14. Zarski JP, Mc Hutchison J, Bronowicki JP, Sturm N, Garcia-Kennedy R, Hodaj E, Truta B, Wright T, Gish R: Rate of natural disease progression in patients with chronic hepatitis C. J Hepatol 38:307-314, 2003
15. Asselah T, Boyer N, Guimont MC, Cazals-Hatem D, Tubach F, Nahon K, Daïkha H, Vidaud D, Martinot M, Vidaud M, Degott C, Valla D, Marcellin P: Liver fibrosis is not associated with steatosis but with necroinflammation in french patients with hepatitis C. Gut 52:1638-1643, 2003
16. Ryder SD, on behalf of the Trent Hepatitis C Study Group: Progression of hepatic fibrois in patients with hepatitis C. A prospective repeat liver biopsy study. Gut 53:451-455, 2004
17. Bedossa P, Poynard T: An algorithm for the grading of activity in chronic hepatitis C. Hepatology 24:289-293, 1996
18. Sindram JW, Marx JJM: Localization of iron in the hepatic acini and bile duct epithelium as a tool for estimation of liver iron overload. Ann NY Acad Sci 526:361-362, 1988
19. Thomas DL, Astemborski J, Rai RM, Anaia FA, Schaeffer M, Galai N, Nolt K, Nelson KE, Strathdee SA, Johnson L, Laeyendecker O, Boitnott J, Wilson LE, Vlahov D: The natural history of hepatitis C virus infection: Host, viral and environmental factors. JAMA 284:450-456, 2000
20. Machicao VI, Bonatti H, Krishna M, Aqel BA, Lukens FJ, Nguyen JH, Rosser BG, Satyanarayana R, Grewal HP, Hewitt WR, Harnois DM, Crook JE, Steers JL, Dickson RC: Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Transplantation 77:84-92, 2004
21. Freeman AJ, Law MG, Kaldor JM, Dore GJ: Predicting progression to cirrhosis in chronic hepatitois C virus infection. J Viral Hepat 10:285-293, 2003
22. Perlemuter G, Letteron P, Carnot F, Zavala F, Pessayre D, Nalpas B, Brechot C: Alcohol and hepatitis C virus core protein additively increase lipid peroxidation and synergistically trigger hepatic cytokine expression in a transgenic mouse model. J Hepatol 39:1020-1027, 2003
23. Saile B, Matthes N, Knittel T, Ramadori G: Transforming growth factor beta and tumor necrosis facto-alpha inhibit both apoptosis and proliferation of activated rat hepatic stellate cells. Hepatology 30:196-202, 1999
24. Rubbia-Brandt L, Quadri R, Abid K, Giostra E, Malé PJ, Mentha G, Spahr L, Zarski JP, Borisch B, Hadengue A, Negro F: Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol 33:106-115, 2000
25. Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G: Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 33:1358-1364, 2001
26. Hourigan LF, Macdonald GA, Purdie D, Whitehall VH, Shorthouse C, Clouston A, Powell EE: Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 29:1215-1219, 1999
27. Castera L, Hezode C, Roudot-Thoraval F, et al.: Worsening of steatosis is an independent factor of fibrosis progression in untreated partients with chronic hepatitis C and paired liver biopsies. Gut 52:288-292, 2003
28. Clouston AD, Jonsson JR, Purdie DM, Macdonald GA, Pandeya N, Shorthouse C, Powell E: Steatosis and chronic hepatitis C: Analysis of fibrosis and stellate cell activation. J Hepatol 34:314-320, 2000
29. Ortiz V, Berenguer M, Rayon JM, Carrasco D, Berenguer J: Contribution of obesity to hepatitis C-related fibrosis progression. Am J Gastroenterol 97:2408-2414, 2002
30. Bressler BL, Guindi M, Tomlinson G, Heathcote J: High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C. Hepatology 38:639-644, 2003
31. Hui JM, Sud A, Farrell GC, Bandara P, Byth K, Kench JG, McCaughan GW, George J: Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression. Gastroenterology 125:1695-1704, 2003
32. Guillyomarc'h A, Mendler MH, Moirand R, et al.: Venesection therapy of insulin resistance-associated hepatic iron overload J Hepatol 53:344-349, 2001
33. Furutani M, Nakashima T, Sumida Y, Hirohma A, Yoh T, Kakisaka Y, Mitsuyoshi H, Senmaru H, Okanoue T: Insulin resistance/beta-cell function and serum ferritin level in non-diabetic patients with hepatitis C virus infection. Liver Int 23:294-299, 2003
34. Day CP, James OF: Steatohepatitis: A tale of two "hits"? Gastroenterology 114:842-845, 1998